Target intelligence / Profile preview

RNA, U7 small nuclear 40 pseudogene (RNU7-40P)

Target
RNU7-40P
Molecular classification
Other, Pseudogene
01

Overview

RNA, U7 small nuclear 40 pseudogene (RNU7-40P) is classified as a pseudogene corresponding to U7 small nuclear RNA, located on human chromosome 12[7][1]. U7 snRNA itself is a functional non-coding RNA component of the U7 small nuclear ribonucleoprotein complex (U7 snRNP) that is essential for 3' end processing of replication-dependent histone pre-mRNAs[2][3]. However, RNU7-40P is a non-functional genomic fragment, not transcribed or translated into a functional product, and is not involved in canonical biological pathways or disease mechanisms[1][4][7][8]. Consequently, it is not considered a therapeutic target, biomarker, or druggable entity. Key details: - As a **pseudogene**, RNU7-40P does not encode a functional RNA or protein[1]. - There is no evidence linking RNU7-40P to any biological functions, disease roles, or known interactions with drugs. - U7 snRNA's functional versions are vital for histone mRNA maturation, but the RNU7-40P pseudogene is an inactive genomic element[2][3][4]. - The presence of “pseudogene” in the name and databases (such as NCBI, GeneCards, HGNC) indicates it is not a valid therapeutic target[1][7][8]. - Its aliases reflect standard gene and pseudogene nomenclature, but there are no functional or therapeutic implications. Thus, there is something incorrect from a drug discovery perspective: RNU7-40P is not a valid target due to its classification as a pseudogene and lack of biological activity or therapeutic implication[1][7].

Other names
U7.40U7.40 pseudogeneRNA, small nuclear U7.40 pseudogene

Beyond the preview

Go deeper on RNA, U7 small nuclear 40 pseudogene (RNU7-40P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U7 small nuclear 40 pseudogene (RNU7-40P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call